A Phase IV, single dose, open labelled, comparative, randomized controlled study to evaluate the immunogenicity and safety of BBIL's JENVAC (Inactivated JE Vaccine) vs. Chinese SA-14-14-2 (Live JE Vaccine) vaccine in healthy volunteers.
Phase of Trial: Phase IV
Latest Information Update: 12 Nov 2019
Price : $35 *
At a glance
- Drugs Japanese encephalitis vaccine (Primary) ; Japanese encephalitis vaccine (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics
- Sponsors Bharat Biotech
- 05 Dec 2018 Status changed from recruiting to completed.
- 19 Mar 2014 New trial record